NCT00524732View on ClinicalTrials.gov

Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age

CompletedOBSERVATIONAL

Enrollment

7,156

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

September 30, 2005

Conditions

PertussisDiphtheria

Interventions

BIOLOGICAL

Tetanus and diphtheria toxoids and acellular pertussis

0.5 mL, Intramuscular

Trial Locations (2)

NS B3K 6R8

Halifax

C1A 7N8

Charlottetown

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00524732 - Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age | Biotech Hunter | Biotech Hunter